Juergen Krause

Description

Details

NameJuergen Krause
PositionFaculty Member
Emailjukrause@upei.ca
Department(s)Business Administration
Phone(902) 620-5078
BuildingMcDougall Hall 417
Websitehttp://business.upei.ca/faculty/juergen-krause

Juergen Krause

Biography

Title: Associate Professor

Juergen Krause earned his Masters degree in Chemistry and his PhD degree in Biochemistry from the University of Konstanz, Germany and performed his postdoctoral studies at the University of Chicago, Illinois. Before moving into education, he spent 22 years in the Pharmaceutical and Biopharmaceutical industry. Juergen worked 18 years for Boehringer Ingelheim Pharmaceuticals in both the European and United States offices before joining Millennium Pharmaceuticals in Cambridge, Massachusetts as Vice President of R&D Strategy & Operations in 2004. During his career, he served in several different operational and strategic capacities, holding senior and executive positions in research and development, manufacturing and quality management, project management, pipeline and portfolio management and strategy development. He also successfully championed global company initiatives and a number of industry/university collaborations and led alliances with other industry partners.

Dr. Krause joined the faculty of the UPEI School of Business in July 2008 as an Associate Professor primarily teaching in the field of Biotech Management.


Recent Citations


Subscribe to Juergen Krause's citation feed

Research Interests

  • Management of science and innovation
  • Biotech cluster formation and development
  • Change and opportunity in the global biotech industry
  • Best practices and strategic portfolio management in biopharmaceutical and biotech sectors
  • Improving cross functional R&D performance
  • Collaborations and alliance models

Other Scholars in Business Administration

    Citations

    Step 1: Select your citations

    TitleAuthor(s)
    Optimizing Productivity in a Matrix StructureKrause, J.
    The degree of coupling of oxidative phosphorylation is varied physiologicallyKrause, J.; Klug, G.; Brdiczka, D.
    Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in menMüller, T. H.; Weisenberger, H.; Brickl, R.; Narjes, H.; Himmelsbach, F.; Krause, J.
    Characterization of Muscarinic Receptor in Guinea Pig Uterus Smooth MuscleDoods, H. N.; Willim, K.; Krause, J.
    The Prince Edward Island Bioscience clusterCasper, S.; Krause, J.; MacNevin, A.
    Localisation of fluorescence-labelled recombinant tissue-type Plasminogen activator (rt-PA) on thrombi in vitroKrause, J.; Deutsch, H.
    Different neuropeptsde Y receptor subtypes in rat and rabbit vas deferensDoods, H. N.; Krause, J.
    Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo.Stang, E.; Krause, J.; Seydel, W.; Berg, T.; Roos, N.
    Microcompartmentation at the mitochondrial surfaceBrdiczka, D.; Knoll, G.; Riesinger, I.; Weiler, U.; Klug, G.; Benz, R.; Krause, J.
    Porin pores of mitochondrial outer membranes from high and low eukaryotic cellsDe Pinto, V.; Ludwig, O.; Krause, J.; Benz, R.; Palmieri, F.
    Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.Tanswell, P.; Seifried, E.; Stang, E.; Krause, J.
    BIBP 3226, the first potent and selective non-peptide Y1 receptor antagonistRudolf, K.; Eberlein, W.; Engel, W.; Beck-Sickinger, AG; Dollinger, H.; Esser, F.; Schnorrengerg, G.; Mihm, G.; Wieland, H. A.; Entzeroth, M.; Wienen, W.; Krause, J.; Doods, H. N.
    Purification and characterization of the pore forming protein of yeast mitochondrial outer membraneLudwig, O.; Krause, J.; Hay, R.; Benz, R.
    The structure and function of the pore in the mitochondrial external membrane / Untersuchungen zur Struktur und Funktion der Pore in der Mitochondrialen AubenmembranKrause, J.
    Pharmacokinetics and isolated liver perfusion of carbohydrate modified recombinant tissue-type plasminogen activatorTanswell, P.; Schlüter, M.; Krause, J.
    Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.Stang, E.; Roos, N.; Schlüter, M.; Berg, T.; Krause, J.
    The binding of glycerol kinase to the outer membrane of rat liver mitochondriaÖstlund, A. K.; Göhring, U.; Krause, J.; Brdiczka, D.
    Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.Tanswell, P.; Heinzel, G.; Greischel, A.; Krause, J.
    Strategic macro-environmental factor analysis for entry into the fish vaccines market in IndiaPallapothu, Mahendra Kumar; Krause, Juergen
    Case study of interprovincial variations in patient access to Oncology drugsBallem, Katherine H. D.; Krause, Juergen
    Pharmaco-dynamics and-kinetics of BIBU 52, a platelet glycoprotein (GP) IIb/IIIa antagonist, and its orally active prodrug BIBU 104 in manMüller, TH; Weisenberger, H.; Brickl, R.; Kirchner, M.; Narjes, H.; Himmelsbach, F.; Guth, B.; Krause, J.
    Hepatic uptake of tissue-type plasminogen activator is saturableKrause, J.; Tanswell, P.
    Aligning R&D and Commercial to Increase ProductivityKrause, J.
    Nonlinear pharmacokinetics and isolated liver perfusion of carbohydrate-modified tissue-type plasminogen activatorTanswell, P.; Schluter, M.; Krause, J.
    Tissue-type plasminogen activator and ovalbumin show colocalization after endocytosis in hepatic cells.Stang, E.; Krause, J.; Berg, T.; Roos, N.
    Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.Krause, J.; Eva, C.; Seeburg, P. H.; Sprengel, R.
    Saturability of clearance of t-PA in three animal species and isolated perfused rat liverTanswell, P.; Heinzel, G.; Greischel, A.; Seydel, W.; Krause, J.
    Localisation of fluorescence labelled recombinant tissue-type plasminogen activator (rt-PA) on thrombi in vitroKrause, J.; Deutsch, H.
    Properties of molecular variants of tissue-type plasminogen activatorKrause, J.; Tanswell, P.
    Die molekularbiologischen Eigenschaften des Gewebetyp-plasminogenactivators und seiner VariantenTanswell, P.; Krause, J.
    Characterization of the receptor mediating the hepatic catabolism of t-PASeydel, W.; Hoffmann, H.; Krause, J.
    Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.Seydel, W.; Stang, E.; Roos, N.; Krause, J.
    Balancing R&D and Commercialization Teams to Maximize Early Market EntryKrause, J.
    Enrichment and biochemical characterization of boundary membrane contact sites from rat-liver mitochondria.Ohlendieck, K.; Riesinger, I.; Adams, V.; Krause, J.; Brdiczka, D.
    Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybridsKrause, J.
    Endocytosis and intracellular processing of t-PA by rat liver cellsSeydel, W.; Hoffmann, H.; Krause, J.
    Alterations in liver mitochondrial function as a result of fasting and exhaustive exercise.Klug, G. A.; Krause, J.; Ostlund, AK; Knoll, G.; Brdiczka, D.
    Tolerability and platelet fibrinogen receptor occupancy (FRO) after oral treatment with BIBU 104 xx in healthy volunteersNarjes, H.; Weisenberger, H.; Muller, TH; Deichsel, G.; Krause, J.
    Hepatic Endocytosis of Tissue-Type Plasminogen Activator with Special Reference to the Sinusoidal CellsWisse, E.; Knook, D. L.; ,
    Pharmacokinetics of Human Tissue-Type Plasminogen ActivatorTanswell, P.; Seifried, E.; Krause, J.

    Step 2: Preview or export the formatted citations

    Theses

    Step 1: Select your citations

    Step 2: Preview or export the formatted citations

    Metrics

    TitleTimes viewedLast viewed
    Optimizing Productivity in a Matrix Structure - ir:429917905:46:18 2014-07-30
    The degree of coupling of oxidative phosphorylation is varied physiologically - ir:430216515:10:26 2014-07-29
    Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men - ir:432317414:40:14 2014-07-28
    Characterization of Muscarinic Receptor in Guinea Pig Uterus Smooth Muscle - ir:420314701:32:44 2014-07-24
    The Prince Edward Island Bioscience cluster - ir:418622214:02:21 2014-07-26
    Localisation of fluorescence-labelled recombinant tissue-type Plasminogen activator (rt-PA) on thrombi in vitro - ir:429218522:09:25 2014-07-27
    Different neuropeptsde Y receptor subtypes in rat and rabbit vas deferens - ir:420218800:38:28 2014-07-29
    Mastitis treatment decision system - ir:282234017:45:39 2014-07-30
    Endocytosis and intracellular processing of tissue-type plasminogen activator by rat liver cells in vivo. - ir:435516114:52:36 2014-07-27
    Microcompartmentation at the mitochondrial surface - ir:416718603:48:20 2014-07-27
    Porin pores of mitochondrial outer membranes from high and low eukaryotic cells - ir:418916319:28:12 2014-07-29
    Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator. - ir:435914206:44:34 2014-07-28
    BIBP 3226, the first potent and selective non-peptide Y1 receptor antagonist - ir:434815000:08:55 2014-07-25
    Genetically modified crops - ir:372247814:07:13 2014-07-29
    Purification and characterization of the pore forming protein of yeast mitochondrial outer membrane - ir:430417016:46:59 2014-07-28
    The structure and function of the pore in the mitochondrial external membrane / Untersuchungen zur Struktur und Funktion der Pore in der Mitochondrialen Aubenmembran - ir:450716803:22:49 2014-07-29
    Pharmacokinetics and isolated liver perfusion of carbohydrate modified recombinant tissue-type plasminogen activator - ir:435816102:11:12 2014-07-28
    Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells. - ir:435617508:33:17 2014-07-28
    The binding of glycerol kinase to the outer membrane of rat liver mitochondria - ir:432717104:10:44 2014-07-30
    Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver. - ir:435717119:11:33 2014-07-28
    Strategic macro-environmental factor analysis for entry into the fish vaccines market in India - ir:442936104:36:32 2014-07-30
    Case study of interprovincial variations in patient access to Oncology drugs - ir:415327005:50:08 2014-07-29
    Pharmaco-dynamics and-kinetics of BIBU 52, a platelet glycoprotein (GP) IIb/IIIa antagonist, and its orally active prodrug BIBU 104 in man - ir:432417708:33:47 2014-07-27
    Hepatic uptake of tissue-type plasminogen activator is saturable - ir:429514018:23:56 2014-07-30
    Aligning R&D and Commercial to Increase Productivity - ir:429821615:10:39 2014-07-29
    Nonlinear pharmacokinetics and isolated liver perfusion of carbohydrate-modified tissue-type plasminogen activator - ir:436119503:32:49 2014-07-29
    Tissue-type plasminogen activator and ovalbumin show colocalization after endocytosis in hepatic cells. - ir:435416719:36:14 2014-07-30
    Aquaculture industry analysis and market attractiveness of fish vaccines in India - ir:414132406:16:11 2014-07-26
    Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. - ir:429315603:53:57 2014-07-27
    Saturability of clearance of t-PA in three animal species and isolated perfused rat liver - ir:436014614:54:03 2014-07-29
    Localisation of fluorescence labelled recombinant tissue-type plasminogen activator (rt-PA) on thrombi in vitro - ir:430020007:23:24 2014-07-28
    Properties of molecular variants of tissue-type plasminogen activator - ir:429614701:31:23 2014-07-24
    Die molekularbiologischen Eigenschaften des Gewebetyp-plasminogenactivators und seiner Varianten - ir:455119018:05:37 2014-07-30
    Characterization of the receptor mediating the hepatic catabolism of t-PA - ir:435118904:04:22 2014-07-27
    Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells. - ir:435014523:36:50 2014-07-27
    Balancing R&D and Commercialization Teams to Maximize Early Market Entry - ir:429720701:30:12 2014-07-24
    Enrichment and biochemical characterization of boundary membrane contact sites from rat-liver mitochondria. - ir:432615415:38:03 2014-07-29
    Catabolism of tissue-type plasminogen activator (t-PA), its variants, mutants and hybrids - ir:429114907:00:51 2014-07-24
    Endocytosis and intracellular processing of t-PA by rat liver cells - ir:435217211:10:44 2014-07-28
    Alterations in liver mitochondrial function as a result of fasting and exhaustive exercise. - ir:428919901:28:40 2014-07-24
    Tolerability and platelet fibrinogen receptor occupancy (FRO) after oral treatment with BIBU 104 xx in healthy volunteers - ir:432518114:48:38 2014-07-27
    Primary healthcare models - ir:871911216:55:26 2014-07-28
    Hepatic Endocytosis of Tissue-Type Plasminogen Activator with Special Reference to the Sinusoidal Cells - ir:436718417:12:13 2014-07-29
    Pharmacokinetics of Human Tissue-Type Plasminogen Activator - ir:436222516:43:07 2014-07-28